# Progress Software Corp: financial statements, quarterly

PRGS · Nasdaq · CIK 876167 · [Technology](/sectors/technology.md) · fiscal year ends Nov 30

Pages: [Overview](/companies/prgs.md) · [Financials](/companies/prgs/financials.md) · [Filings](/companies/prgs/filings.md) · [Insiders](/companies/prgs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/prgs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-11-30) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | Q4 FY2024 (2024-11-30) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | Q4 FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [177 d](/filings/0000876167-26-000008.md) | [185](/filings/0000876167-25-000052.md) | [175](/filings/0000876167-25-000085.md) | [179](/filings/0000876167-25-000143.md) | [215 d](/filings/0000876167-26-000008.md) | [238](/filings/0000876167-26-000051.md) | [237](/filings/0000876167-26-000078.md) | [250](/filings/0000876167-26-000111.md) | [253 d](/filings/0000876167-26-000008.md) | [248](/filings/0000876167-26-000051.md) | [253](/filings/0000876167-26-000078.md) | [246](/filings/0000876167-26-000111.md) |
| Cost of revenue | $m | [33.7 d](/filings/0000876167-26-000008.md) | [32.8](/filings/0000876167-25-000052.md) | [32.1](/filings/0000876167-25-000085.md) | [29.1](/filings/0000876167-25-000143.md) | [36.5 d](/filings/0000876167-26-000008.md) | [46.2](/filings/0000876167-26-000051.md) | [47.3](/filings/0000876167-26-000078.md) | [47.5](/filings/0000876167-26-000111.md) | [46.5 d](/filings/0000876167-26-000008.md) | [43.9](/filings/0000876167-26-000051.md) | [44.9](/filings/0000876167-26-000078.md) | [42.5](/filings/0000876167-26-000111.md) |
| Gross profit | $m | [143 d](/filings/0000876167-26-000008.md) | [152](/filings/0000876167-25-000052.md) | [143](/filings/0000876167-25-000085.md) | [150](/filings/0000876167-25-000143.md) | [178 d](/filings/0000876167-26-000008.md) | [192](/filings/0000876167-26-000051.md) | [190](/filings/0000876167-26-000078.md) | [202](/filings/0000876167-26-000111.md) | [206 d](/filings/0000876167-26-000008.md) | [204](/filings/0000876167-26-000051.md) | [209](/filings/0000876167-26-000078.md) | [204](/filings/0000876167-26-000111.md) |
| Operating income | $m | [22.5 d](/filings/0000876167-26-000008.md) | [35.0](/filings/0000876167-25-000052.md) | [27.1](/filings/0000876167-25-000085.md) | [40.3](/filings/0000876167-25-000143.md) | [21.5 d](/filings/0000876167-26-000008.md) | [32.4](/filings/0000876167-26-000051.md) | [38.6](/filings/0000876167-26-000078.md) | [43.9](/filings/0000876167-26-000111.md) | [38.4 d](/filings/0000876167-26-000008.md) | [46.5](/filings/0000876167-26-000051.md) | [45.2](/filings/0000876167-26-000078.md) | [46.6](/filings/0000876167-26-000111.md) |
| Interest expense | $m | [7.9 d](/filings/0000876167-24-000031.md) | [7.3](/filings/0000876167-24-000080.md) | [7.0](/filings/0000876167-25-000085.md) | [6.8](/filings/0000876167-25-000143.md) | [10.9 d](/filings/0000876167-26-000008.md) | [18.4](/filings/0000876167-26-000051.md) | [18.1](/filings/0000876167-26-000078.md) | [17.7](/filings/0000876167-26-000111.md) | [16.5 d](/filings/0000876167-26-000008.md) | [15.2](/filings/0000876167-26-000051.md) | [15.9](/filings/0000876167-26-000078.md) | [16.9](/filings/0000876167-26-000111.md) |
| Income tax | $m | [(1.2) d](/filings/0000876167-26-000008.md) | [5.0](/filings/0000876167-25-000052.md) | [3.9](/filings/0000876167-25-000085.md) | [5.8](/filings/0000876167-25-000143.md) | [11.1 d](/filings/0000876167-26-000008.md) | [2.4](/filings/0000876167-26-000051.md) | [2.8](/filings/0000876167-26-000078.md) | [6.8](/filings/0000876167-26-000111.md) | [(3.5) d](/filings/0000876167-26-000008.md) | [7.5](/filings/0000876167-26-000051.md) | [7.8](/filings/0000876167-26-000078.md) | [6.8](/filings/0000876167-26-000111.md) |
| Net income | $m | [15.3 d](/filings/0000876167-26-000008.md) | [22.6](/filings/0000876167-25-000052.md) | [16.2](/filings/0000876167-25-000085.md) | [28.5](/filings/0000876167-25-000143.md) | [1.1 d](/filings/0000876167-26-000008.md) | [10.9](/filings/0000876167-26-000051.md) | [17.0](/filings/0000876167-26-000078.md) | [19.4](/filings/0000876167-26-000111.md) | [25.7 d](/filings/0000876167-26-000008.md) | [22.8](/filings/0000876167-26-000051.md) | [21.1](/filings/0000876167-26-000078.md) | [22.8](/filings/0000876167-26-000111.md) |
| Diluted EPS | $ per share | not reported | [0.51](/filings/0000876167-25-000052.md) | [0.37](/filings/0000876167-25-000085.md) | [0.65](/filings/0000876167-25-000143.md) | not reported | [0.24](/filings/0000876167-26-000051.md) | [0.39](/filings/0000876167-26-000078.md) | [0.44](/filings/0000876167-26-000111.md) | not reported | [0.53](/filings/0000876167-26-000051.md) | [0.50](/filings/0000876167-26-000078.md) | [0.55](/filings/0000876167-26-000111.md) |
| Basic EPS | $ per share | not reported | [0.52](/filings/0000876167-25-000052.md) | [0.37](/filings/0000876167-25-000085.md) | [0.66](/filings/0000876167-25-000143.md) | not reported | [0.25](/filings/0000876167-26-000051.md) | [0.40](/filings/0000876167-26-000078.md) | [0.45](/filings/0000876167-26-000111.md) | not reported | [0.54](/filings/0000876167-26-000051.md) | [0.50](/filings/0000876167-26-000078.md) | [0.55](/filings/0000876167-26-000111.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-11-30) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | FY2024 (2024-11-30) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [127](/filings/0000876167-25-000010.md) | [133](/filings/0000876167-24-000080.md) | [190](/filings/0000876167-24-000127.md) | [233](/filings/0000876167-24-000160.md) | [118](/filings/0000876167-26-000008.md) | [124](/filings/0000876167-25-000052.md) | [102](/filings/0000876167-25-000085.md) | [99.0](/filings/0000876167-25-000143.md) | [94.8](/filings/0000876167-26-000111.md) | [113](/filings/0000876167-26-000051.md) | [103](/filings/0000876167-26-000078.md) | [114](/filings/0000876167-26-000111.md) |
| Current assets | $m | [331](/filings/0000876167-25-000010.md) | [297](/filings/0000876167-24-000080.md) | [343](/filings/0000876167-24-000127.md) | [389](/filings/0000876167-24-000160.md) | [369](/filings/0000876167-26-000008.md) | [341](/filings/0000876167-25-000052.md) | [326](/filings/0000876167-25-000085.md) | [336](/filings/0000876167-25-000143.md) | [400](/filings/0000876167-26-000111.md) | [370](/filings/0000876167-26-000051.md) | [337](/filings/0000876167-26-000078.md) | [330](/filings/0000876167-26-000111.md) |
| Total assets | $m | [1,603](/filings/0000876167-25-000010.md) | [1,548](/filings/0000876167-24-000080.md) | [1,586](/filings/0000876167-24-000127.md) | [1,620](/filings/0000876167-24-000160.md) | [2,527](/filings/0000876167-26-000008.md) | [2,462](/filings/0000876167-25-000052.md) | [2,414](/filings/0000876167-25-000085.md) | [2,422](/filings/0000876167-25-000143.md) | [2,458](/filings/0000876167-26-000111.md) | [2,395](/filings/0000876167-26-000051.md) | [2,346](/filings/0000876167-26-000078.md) | [2,303](/filings/0000876167-26-000111.md) |
| Current liabilities | $m | [352](/filings/0000876167-25-000010.md) | [312](/filings/0000876167-24-000080.md) | [307](/filings/0000876167-24-000127.md) | [315](/filings/0000876167-24-000160.md) | [455](/filings/0000876167-26-000008.md) | [429](/filings/0000876167-25-000052.md) | [750](/filings/0000876167-25-000085.md) | [770](/filings/0000876167-25-000143.md) | [810](/filings/0000876167-26-000111.md) | [788](/filings/0000876167-26-000051.md) | [416](/filings/0000876167-26-000078.md) | [415](/filings/0000876167-26-000111.md) |
| Long-term debt | $m | [711](/filings/0000876167-24-000031.md) | not reported | not reported | not reported | [1,526](/filings/0000876167-26-000008.md) | [1,510](/filings/0000876167-25-000052.md) | [1,100](/filings/0000876167-25-000085.md) | [1,061](/filings/0000876167-25-000143.md) | [1,041](/filings/0000876167-26-000111.md) | [982](/filings/0000876167-26-000051.md) | [1,292](/filings/0000876167-26-000078.md) | [1,233](/filings/0000876167-26-000111.md) |
| Current portion of debt | $m | [13.1](/filings/0000876167-25-000010.md) | [0.0](/filings/0000876167-24-000080.md) | [0.0](/filings/0000876167-24-000127.md) | [0.0](/filings/0000876167-24-000160.md) | [0.0](/filings/0000876167-26-000008.md) | not reported | not reported | not reported | [359](/filings/0000876167-26-000111.md) | [360](/filings/0000876167-26-000051.md) | [0.0](/filings/0000876167-26-000078.md) | [0.0](/filings/0000876167-26-000111.md) |
| Shareholders' equity | $m | [460](/filings/0000876167-26-000008.md) | [462](/filings/0000876167-25-000085.md) | [402](/filings/0000876167-25-000143.md) | [426](/filings/0000876167-25-000143.md) | [439](/filings/0000876167-26-000111.md) | [432](/filings/0000876167-26-000078.md) | [453](/filings/0000876167-26-000111.md) | [478](/filings/0000876167-26-000111.md) | [478](/filings/0000876167-26-000111.md) | [499](/filings/0000876167-26-000078.md) | [506](/filings/0000876167-26-000111.md) | [530](/filings/0000876167-26-000111.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-11-30) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | Q4 FY2024 (2024-11-30) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | Q4 FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [33.2 d](/filings/0000876167-26-000008.md) | [70.5](/filings/0000876167-25-000052.md) | [63.7 d](/filings/0000876167-25-000085.md) | [57.7 d](/filings/0000876167-25-000143.md) | [19.7 d](/filings/0000876167-26-000008.md) | [68.9](/filings/0000876167-26-000051.md) | [30.0 d](/filings/0000876167-26-000078.md) | [73.4 d](/filings/0000876167-26-000111.md) | [62.8 d](/filings/0000876167-26-000008.md) | [98.6](/filings/0000876167-26-000051.md) | [78.8 d](/filings/0000876167-26-000078.md) | [88.0 d](/filings/0000876167-26-000111.md) |
| Capital expenditure | $m | [2.4 d](/filings/0000876167-26-000008.md) | [0.3](/filings/0000876167-25-000052.md) | [1.0 d](/filings/0000876167-25-000085.md) | [1.1 d](/filings/0000876167-25-000143.md) | [2.9 d](/filings/0000876167-26-000008.md) | [1.3](/filings/0000876167-26-000051.md) | [0.5 d](/filings/0000876167-26-000078.md) | [1.1 d](/filings/0000876167-26-000111.md) | [2.9 d](/filings/0000876167-26-000008.md) | [2.7](/filings/0000876167-26-000051.md) | [1.9 d](/filings/0000876167-26-000078.md) | [1.7 d](/filings/0000876167-26-000111.md) |
| Dividends paid | $m | [7.9 d](/filings/0000876167-26-000008.md) | [8.2](/filings/0000876167-25-000052.md) | [8.0 d](/filings/0000876167-25-000085.md) | [7.7 d](/filings/0000876167-25-000143.md) | [7.6 d](/filings/0000876167-26-000008.md) | [0.4](/filings/0000876167-26-000051.md) | [0.3 d](/filings/0000876167-26-000078.md) | [0.0 d](/filings/0000876167-26-000111.md) | [0.1 d](/filings/0000876167-26-000008.md) | [0.2](/filings/0000876167-26-000051.md) | [0.2 d](/filings/0000876167-26-000078.md) | [0.0 d](/filings/0000876167-26-000111.md) |
| Share repurchases | $m | [4.0 d](/filings/0000876167-26-000008.md) | [22.5](/filings/0000876167-25-000052.md) | [49.9 d](/filings/0000876167-25-000085.md) | [14.3 d](/filings/0000876167-25-000143.md) | [0.0 d](/filings/0000876167-26-000008.md) | [30.1](/filings/0000876167-26-000051.md) | [20.0 d](/filings/0000876167-26-000078.md) | [15.0 d](/filings/0000876167-26-000111.md) | [40.0 d](/filings/0000876167-26-000008.md) | [20.4](/filings/0000876167-26-000051.md) | [34.7 d](/filings/0000876167-26-000078.md) | [16.9 d](/filings/0000876167-26-000111.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-02-28) | Q2 FY2023 (2023-05-31) | Q3 FY2023 (2023-08-31) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [44.4](/filings/0000876167-24-000080.md) | [44.5](/filings/0000876167-24-000127.md) | [45.0](/filings/0000876167-24-000160.md) | [44.8](/filings/0000876167-25-000052.md) | [44.0](/filings/0000876167-25-000085.md) | [43.7](/filings/0000876167-25-000143.md) | [44.9](/filings/0000876167-26-000051.md) | [44.2](/filings/0000876167-26-000078.md) | [43.7](/filings/0000876167-26-000111.md) | [42.7](/filings/0000876167-26-000051.md) | [42.3](/filings/0000876167-26-000078.md) | [41.5](/filings/0000876167-26-000111.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 40,874,192 at 2026-09-28, from the cover of the [10-Q filed 2026-09-30](/filings/0000876167-26-000111.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.
